Kampanjeplan Neuland Laboratories Limited
Om selskapet Neuland Laboratories Limited
Neuland Laboratories Limited производит и продает активные фармацевтические ингредиенты (АФИ) в Индии, Европе, США и за рубежом. АФИ компании используются в различных терапевтических областях, включая противоастматические, сердечно-сосудистые, противогрибковые, противосудорожные средства, средства для центральной нервной системы, фторхинолоны, антипсихотические, антибактериальные и противопаркинсонические средства. Он также предоставляет индивидуальные производственные решения, а также услуги по синтезу пептидов. flere detaljer| ISIN | INE794A01010 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | inr |
| Валюта отчета | inr |
| Див.доход ао | 0.1296 |
| Дивиденд ао | 14 |
| Сайт | https://www.neulandlabs.com |
| Цена ао | 11601.2 |
| Prisendring per dag: | 0% (10949.1) |
|---|---|
| Prisendring per uke: | -0.422% (10995.5) |
| Prisendring per måned: | -21.3% (13912.4) |
| Prisendring over 3 måneder: | -34.47% (16709.3) |
| Prisendring over seks måneder: | -12.55% (12520.4) |
| Prisendring per år: | +50.64% (7268.5) |
| Prisendring over 3 år: | +957.37% (1035.5) |
| Prisendring over 5 år: | +2 172.07% (481.9) |
| Prisendring over 10 år: | 0% (10949.1) |
| Prisendring siden begynnelsen av året: | -25.88% (14771.2) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
|---|---|---|---|
| Matthews India Active ETF | 3.39645 | 19.19 | |
| iShares MSCI India Small-Cap ETF | 0.28369 | 0.4625 | 0.96163 |
| SPDR S&P Emerging Markets Small Cap ETF | 0.10859 | 5.46 | 3.03583 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.10491 | 7.67 | 2.7853 |
WisdomTree India Earnings Fund
|
0.10482 | 5.23 | 1.65591 |
| Avantis Responsible Emerging Markets Equity ETF | 0.09671 | 17.6 | 3.1719 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.04 | 9.39 | 3.09932 |
| Avantis Emerging Markets Value ETF | 0.03932 | 14.12 | 4.22231 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.03366 | 15.96 | 3.34087 |
| Avantis Emerging Markets Equity ETF | 0.02505 | 8.77 | 3.60513 |
| Dimensional Emerging Markets Value ETF | 0.0128 | 17.07 | 4.19508 |
| SPDR Portfolio Emerging Markets ETF | 0.00769 | 11.59 | 3.1879 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00561 | 13.06 | 3.62488 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.3 | 10.85 | 2.86 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Dr. Davuluri Rama Mohan Rao | Executive Chairman & Chief Promoter and Member of Scientific Advisory Board | 60M | 1944 (81 år) |
| Mr. Davuluri Sucheth Rao | Vice Chairman & CEO | 57.5M | 1975 (50 år) |
| Mr. Davuluri Saharsh Rao | Vice Chairman & MD | 57.5M | 1979 (46 år) |
| Mr. Abhijit Majumdar | Chief Financial Officer | N/A | |
| Ms. Sarada Bhamidipati | Company Secretary & Compliance Officer | N/A | |
| Mr. Y. Sudheer | Senior Vice President of Global API Sales | N/A | 1963 (62 år) |
| Dr. Sharadsrikar Venkatesan Kotturi | Chief Scientific Officer & Member of Scientific Advisory Board | ||
| Mr. Sudheer Yarabolu | Senior VP of Global Head Sales & BD | ||
| Mr. Hemchandra Peruvelli | Chief Human Resources Officer | 1972 (53 år) | |
| Mr. N. Sundar | Chief Procurement Officer | 1968 (57 år) |
Adresse: India, Hyderabad, Phoenix IVY Building - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.neulandlabs.com
Nettsted: https://www.neulandlabs.com
